Chemed (CHE) Bank of America Home Care Conference summary
Event summary combining transcript, slides, and related documents.
Bank of America Home Care Conference summary
8 Jul, 2026Growth outlook and industry trends
Organic census growth exceeded 10% YTD, with expectations of 8–10% volume growth in 2025, supported by nine quarters of net clinical capacity expansion and strong demand.
Anticipated price increase in October 2025 is expected to drive low double-digit top-line growth.
Demographic tailwinds from the aging baby boomer population are projected to support 8–10% annual industry growth over the next decade, with Florida likely outpacing the national average.
Increased awareness and earlier adoption of hospice care, accelerated by the pandemic, are expected to improve patient outcomes and reduce Medicare costs.
Staffing, retention, and culture
Staff growth will match census growth, with a methodical approach to expanding clinical capacity and a focus on high-quality care.
New hires come from competitors, workforce reentry, and increasingly younger clinicians, reflecting a shift in industry perception.
Improved retention has reduced hiring needs, allowing for greater selectivity and stability in workforce planning.
Retention gains are attributed to competitive compensation, enhanced benefits, and a strong, locally empowered culture.
M&A and expansion strategy
Appetite for acquisitions remains high, with a focus on strategic, culturally aligned targets in attractive states, especially Florida.
M&A approach is methodical, prioritizing fit and risk-adjusted returns over rapid expansion.
De novo growth continues, particularly in CON states, with recent openings in Florida and California.
Latest events from Chemed
- VITAS drives robust growth and margin expansion, positioning for industry-leading hospice consolidation.CHE
43rd Annual J.P. Morgan Healthcare Conference 20259 Jul 2026 - VITAS drives strong growth while Roto-Rooter adapts to competition and digital marketing shifts.CHE
UBS Global Healthcare Conference 20248 Jul 2026 - Admissions growth and CAP mitigation are ahead of plan, with strong execution in new markets.CHE
RBC Capital Markets Global Healthcare Conference 202620 May 2026 - Raised hospice growth outlook, selective expansion, and digital strategies support margin gains.CHE
Bank of America Global Healthcare Conference 202612 May 2026 - VITAS outperformed, boosting guidance, while Roto-Rooter faced margin pressure and revenue decline.CHE
Q1 202628 Apr 2026 - Proxy details director elections, auditor ratification, pay-for-performance, and strong governance.CHE
Proxy filing9 Apr 2026 - 2025 revenue up 4.1%, but margins and EPS fell; 2026 outlook is for stronger growth.CHE
Q4 20257 Apr 2026 - Proxy covers director elections, auditor ratification, say-on-pay, and strong governance practices.CHE
Proxy filing6 Apr 2026 - VITAS shows strong growth and margin prospects, while Roto-Rooter faces a pivotal recovery year.CHE
Oppenheimer 36th Annual Healthcare MedTech & Services Conference19 Mar 2026